GeneMind Biosciences

GeneMind Biosciences, founded in 2012, is a pioneering player in the Biotechnology industry. The company's relentless pursuit of innovation and exploration has led to the development of a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences aims to empower clinicians and researchers by providing superior gene sequencing solutions. The recent CNY400.00M Series C investment on 02 August 2023 shows strong support from key investors including KingMed Diagnostics, Guoxin Investment, SZHTI Group, Caixin Capital, Changzhou Shuangye Venture Capital, Guochuang Zhiyuan. This signifies a high level of confidence in GeneMind's potential for growth and success in the genomics field. The company's innovative technology represents a pinnacle achievement in gene sequencing, enabling entrepreneurs to propel their research and advancements. GeneMind's steadfast efforts in tackling obstacles have positioned them to conquer new heights in genomics, shaping the future of precision gene sequencing.